Uncommon Equities provides company-paid research for promising public small and microcap companies that need to have their stories told in a balanced, professional manner. The co-founders are Paul Resnik, CFA, Director of Research and Senior Research Analyst, and Denise Resnik, Senior Research Analyst. Paul Resnik is a Chartered Financial Analyst and Registered Supervisory Analyst with over 40 years of research and management experience in major brokerage firms and independent research firms. Mr. Resnik is the President of Resnik Asset Management Co., Inc, a registered investment advisor, which has been managing large cap equity portfolios for high net worth investors since 1995. He graduated from Hobart College with a Bachelor of Arts in Economics. Denise Resnik principally conducts financial analysis of emerging, biotech companies capitalizing on her extensive consulting career in the pharmaceutical industry. Her industry experience spans both large global pharmaceutical companies and smaller biotech companies in the area of clinical research. Ms. Resnik holds a Bachelor of Arts degree in Biology from Clark University and a Masters of Science degree in Pharmacology from Northeastern University.